Connect with us

Science

NASA abandons InSight mission to crack the surface of Mars – Yahoo Finance Australia

Martian soil does not behave in the way NASA engineers expected.

Published

on

post featured image

San Diego, Calif, Jan. 15, 2021 (GLOBE NEWSWIRE) — Emerald Bioscience, Inc. (OTCQB: EMBI) (EMBI or the Company), a biopharmaceutical company focused on developing proprietary, synthetic cannabinoid-derived molecules to treat glaucoma and other diseases with significant unmet need, has changed its name from Emerald Bioscience, Inc. to Skye Bioscience, Inc. The Company will trade under its new ticker symbol, SKYE, on the OTC effective at market open on Tuesday, January 19, 2021. About Emerald Bioscience,…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending